Farmanguinhos Fiocruz Opposition, Eculizumab, (Br0708909 0/ Us2007006606 / Wo 2007/106585)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Farmanguinhos Fiocruz opposition, Eculizumab, (BR12 2017 024057 9 / PCT US2007006606 / WO 2007/106585)
Countries: Brazil Date: 2021
-
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)
Countries: India Date: 2021
-
Cancer Patient Aid Association (CPAA) opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Entrepreneurship Development Center opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Prathiba Sivasubramanian opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Keelu Lakshminarayana opposition, Molnupiravir, (202017019418)
Countries: India Date: 2021
-
Delhi Network of Positive People opposition, Lenacapavir, (201917006277)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017010006)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017007904)
Countries: India Date: 2021
-
DNP+ opposition, Pibrentasvir, (201818021052 (Divisional of 1310/DELNP/2013))
Countries: India Date: 2021